Drone Stock Review, Cameron Chell

Draganfly (DPRO) the Tesla of Drones, Locked and Loaded.

Closes $20 Million Raise.Uplists to NASDAQ.Pilot Training for First Responders Firefighters, Search and Rescue Commences.Reports Record Revenues for Second Quarter.Shareholder Update and...

Hapbee (HAPB) Expands Leadership Team to Support Aggressive Growth Strategy

VANCOUVER, BC, Aug. 6, 2021 /CNW/ - Hapbee Technologies, Inc. (TSXV: HAPB) (OTCQB: HAPBF) (FSE: HA1) ("Hapbee" or the "Company"), the leading wearable, wellness technology company has...
Draganfly, Drone Stock Review

Draganfly (DPRO) Closes $20 Million Public Offering. Now NASDAQ Listed.

Los Angeles, CA, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Draganfly Inc. (Nasdaq: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), a...

With Hapbee (HAPBF) Who Needs, Drugs, Caffeine or Nicotine?

Record 1 Million Hours of Mood Stimulation Served by Hapbee (HAPBF). TRADING AT THE LOWER END OF...
Psychedelic Stock Review

Are Psychedelics the New Prozac?

Amidst a national epidemic of opioid abuse, and suicides the need for new therapeutics has gained greater urgency. In it's first step to...
cybin

Cybin (CLXPF CYBN) Gets $8.00 Price Target From H.C. Wainwright.

Advancing Multiple Psychedelics in Multiple Indications; Initiating With a Buy and $8 Price Target.

Atai Life Sciences (ATAI) Founder Christian Angermayer Interview.(VIDEO)

Best Psychedelic related interview we've seen yet. Christian states, "I think ultimately, the total addressable market is 100% of the world population!"

I Use Ketamine for Depression – Here’s How It Works.

FREETHINK: When first manufactured as an anesthetic for humans and animals in 1962, doctors had no intention of prescribing ketamine for depression....

Mitesco’s (MITI) CEO Featured In Yahoo News Video.

Michael C. Howe, CEO of Mitesco's 'Good Clinic' and Original Partner of CVS the Acquired 'Minute Clinic' on Yahoo's Finance Channel....

Citius Pharma (CTXR) $2.15. Price Target of $8.00 Maintained, Post Safety and Efficacy Review.

Investment Banker Buy Rating Maintained: DSMB Gives the Thumbs Up – Data in Early 2022. CITIUS NEWS ARCHIVE

Latest article

Ardelyx (ARDX) Reports First Quarter 2024 Showing $204 Million in Cash!

When we added Ardelyx (ARDX) to the Watch List in November of 2022, the market cap near $80 million. Now it's...

GeoVax to Provide Corporate Update on Tuesday May 14, 2024.

Still our favorite biotech microcap, still our favorite management team, and our favorite risk to reward idea with a $4 million market...

NovaVax (NVAX) Roars Higher, Gaining 225% a $1.2 Billion Increase, at the Blink of...

Sanofi (SNY) Announces Partnership - $500 Million Upfront, plus $700 million in Milestones with NovaVax (NVAX). And some investors say Covid is...